Dr. Martens (DOCS) Share Price, News & Analysis

Company Overview

Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage. Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people. The company continues to honour the brand's heritage through its 'Made in England' footwear, manufactured at its original Northamptonshire factory, while meeting global demand from multiple high-quality production sites across Asia. All our products are made with an unwavering commitment to craft, combined with innovative techniques. A brand built to put a bounce in the step of those who stand out from the crowd, Dr. Martens is available through Direct-to-Consumer (Retail and Ecommerce) and Wholesale channels. The brand's collections range from its Original silhouettes - The Icons such as the 1460 boot, 1461 shoe, 2976 Chelsea boot, and Adrian loafer - to modern franchises like the Zebzag, Buzz, and Lowell. The lineup also includes an extensive range of sandals, a dedicated Kids collection, and a curated selection of bags, small leather goods, and accessories. Every Dr. Martens product reflects craftsmanship, heritage, timeless style, comfort, and versatility. Having transcended generations, the brand stays as relevant today as it was at its inception. Its signature yellow welt stitching, grooved sole edges, and scripted "With Bouncing Soles" heel loops remain iconic symbols recognised around the world. Dr. Martens plc (DOCS.L) is listed on the main market of the London Stock Exchange and is a constituent of the FTSE 250 index. For more information, visit www.drmartens.com or www.drmartensplc.com

Key Stats

• Today's Range: 65.56 to 69.30
• 50-Day Range: 63.95 to 81.80
• 52-Week Range: 59.15 to 95.55
• Volume: 313,815 shs
• Average Volume: 6.14 million shs
• Market Capitalization: £634.60 million
• P/E Ratio: 27.63
• Dividend Yield: 3.88%
• Price Target: GBX 105
• Consensus Rating: Moderate Buy

Dr. Martens Stock Analysis - MarketRank™

Dr. Martens scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Dr. Martens has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Dr. Martens has a consensus price target of GBX 105, representing about 58.4% upside from its current price of GBX 66.30.

Amount of Analyst Coverage

Dr. Martens has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Dr. Martens is 27.63, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.11.

Price to Earnings Ratio vs. Sector

The P/E ratio of Dr. Martens is 27.63, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 26.98.

Price to Earnings Growth Ratio

Dr. Martens has a PEG Ratio of 6.40. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Dr. Martens has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DOCS.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Dr. Martens is a leading dividend payer. It pays a dividend yield of 3.88%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Dr. Martens does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Dr. Martens is 106.25%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 3 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.

Company Ownership

• Score: 2.7 / 5
• Insider Trading: Selling Shares

Cluster Insider Buying

2 insiders have purchased shares of Dr. Martens in the last three months. Multiple insiders buying is a strong bullish signal.

Insider Buying vs. Insider Selling

In the past three months, Dr. Martens insiders have sold 23,908.58% more of their company's stock than they have bought. Specifically, they have bought £601.12 in company stock and sold £144,320.40 in company stock.

Percentage Held by Insiders

2.94% of the stock of Dr. Martens is held by insiders.

Percentage Held by Institutions

38.28% of the stock of Dr. Martens is held by institutions.

Company Calendar

• Last Earnings: 5/19/2026
• Today: 10/29/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Discretionary
• Industry: Textiles, Apparel & Luxury Goods
• Sub-Industry: N/A
• Current Symbol: LON:DOCS
• CIK: N/A
• Web: www.drmartensplc.com
• Phone: 44 12 1415 7047
• Fax: N/A
• Employees: 890
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Dr. Martens: GBX 105
• High Price Target: GBX 110
• Low Price Target: GBX 100
• Potential Upside/Downside: +58.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 2.40
• Trailing P/E Ratio: 27.63
• Forward P/E Ratio: 25.69
• P/E Growth: 6.4
• Net Income: £68.97 million
• Net Margins: 3.11%
• Pretax Margin: N/A
• Return on Equity: 6.89%
• Return on Assets: 8.12%

Debt

• Debt-to-Equity Ratio: 108.85
• Current Ratio: 2.61
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: £764.90 million
• Price / Sales: 0.83
• Cash Flow: GBX 4.64 per share
• Price / Cash Flow: 14.29
• Book Value: GBX 37.80 per share
• Price / Book: 1.75

Miscellaneous

• Outstanding Shares: 957,170,000
• Free Float: N/A
• Market Cap: £634.60 million
• Optionable: Not Optionable
• Beta: 0.26